Delivery Order SPE2DB22D1200-SPE2DB24FN3LS

Award Date 7/2/24
Potential Completion Date 7/3/24
Potential Value $3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of 100 tablets of 36 mg extended-release methylphenidate, a prescription medication, to the Defense Logistics Agency (DLA). The contract, worth $2,257.87, was awarded to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, on August 28, 2024. The contract is a firm fixed-price delivery order with an ultimate completion date of August 29, 2024. This contract is not a set-aside, and it appears to be a child contract of a larger...
This federal contract award is for the delivery of 100 tablets of 36 mg Methylphenidate ER, a prescription medication, to the Defense Logistics Agency (DLA). The $1,168.33 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on May 14, 2025 with a completion date of May 15, 2025. The contract is not set aside for any specific business size or socioeconomic status. Amerisourcebergen holds a significant $999,999,999.00 Indefinite...
This federal contract award is for the delivery of 100 tablets of 27 mg extended-release methylphenidate, a prescription medication, to the Defense Logistics Agency (DLA) Troop Support Medical, a division of the U.S. Department of Defense. The $1,252.62 fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on August 20, 2024, with an ultimate completion date of August 21, 2024. This award is part of a larger Indefinite Delivery Contract...
This federal contract award is for the delivery of 4,564,659,978 tablets of methylphenidate extended-release (10 mg) to the Defense Logistics Agency (DLA), a defense agency under the Department of Defense. The fixed-price, firm-fixed delivery order contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical supplier, for a total ceiling value of $2,153.22. The contract has an ultimate completion date of May 21, 2024. Amerisourcebergen holds a significant Indefinite Delivery...
This federal contract award is for the delivery of 4,564,084,308 tablets of methylphenidate extended-release 36 mg to the Defense Logistics Agency (DLA) Troop Support Medical program, which supports medical treatment facilities for the U.S. Department of Defense. The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation, on March 26, 2024 as a firm fixed price delivery order worth $1,602.48. The...
This federal contract award is for the delivery of 100 tablets of 18 mg methylphenidate extended-release medication. The contract, valued at $4,225.94, was awarded to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The award is a delivery order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC...
This federal contract award is for the delivery of 100 tablets of 54 mg Methylphenidate ER (extended-release) to the Defense Logistics Agency (DLA). The $2,525.31 firm fixed-price contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on December 10, 2024, with a completion date of December 11, 2024. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with...
This federal contract award is for the delivery of 4,566,810,759 tablets of Methylphenidate ER 36 mg, a prescription medication, to the Defense Logistics Agency (DLA). The $1,646.73 firm fixed-price contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on December 30, 2024, with a completion date of December 31, 2024. This is a delivery order under an Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop...
This federal contract award is for the delivery of 100 tablets of 18 mg methylphenidate extended-release (ER) to the Defense Logistics Agency (DLA). The $1,751.55 firm fixed-price delivery order was issued to the prime contractor, Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of March 12, 2024 and was awarded on March 11, 2024. No set-aside designation was used for this open competition award....
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 4,564,186,397 tablets of Methylphenidate ER 27 mg. The contract has a ceiling value of $1,693.74 and a period of performance through April 8, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded by DLA to Amerisourcebergen Drug Corp, with a potential value of...
  • SPE2DB22D1200
    Indefinite Delivery Contract
  • SPE2DB22D1200-SPE2DB24FN3LS
    Delivery Order

This federal contract award is for the delivery of 100 tablets of 36 mg Extended Release Methylphenidate, a prescription medication, to the Defense Logistics Agency (DLA). The contract, awarded to Amerisourcebergen Drug Corp's Corporate Office Division, has a firm fixed price of $2,992.12 and a completion date of July 3, 2024.

The contract is a Delivery Order placed under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025. This IDC serves as the primary vehicle for Amerisourcebergen to supply a wide range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense globally. The current award does not have a set-aside designation.

Generated 10/1/24, 11:39 AM